Skip to main content
Clinical Trials/NCT04467372
NCT04467372
Completed
Not Applicable

The Effects Supplementation of Tart Cherry or Placebo on the Gut Microbiome, Inflammation, Oxidative Stress, and Health-related Outcomes.

Ohio University1 site in 1 country70 target enrollmentMarch 18, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammation
Sponsor
Ohio University
Enrollment
70
Locations
1
Primary Endpoint
Changes in glucose regulation assessed via glycated albumin (%).
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.

Detailed Description

Participants will consume a tart cherry or placebo product for 30 days and attend 5 visits in the Exercise Physiology Lab at Ohio University over the 30 day period. They will self-collect a stool sample at baseline, 14 days and 30 days after supplementation. Blood samples will be taken at baseline, 7 days, 14 days, and 30 days after supplementation. Throughout the study participates will rate symptoms (stomach, head, etc.), pain and sleep quality using an online survey for which the link will be emailed. Participants will maintain normal diet and exercise routine and to track these for the duration of the study.

Registry
clinicaltrials.gov
Start Date
March 18, 2019
End Date
July 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Angela Hillman

Assistant Professor

Ohio University

Eligibility Criteria

Inclusion Criteria

  • 18-55 years old
  • participate in 150 minutes of exercise per week
  • non-smoker
  • have no known allergy to cherries or cherry juice
  • are not taking food supplements (turmeric/curcumin, cherry products, greens, etc.). -You must have access to the internet and be willing to record your food intake, physical activity and sleep quality/duration during the study.

Exclusion Criteria

  • not 18-55 years old.
  • have quit smoking less than one year ago.
  • have been diagnosed with a metabolic disorder such as diabetes, thyroid disorder, or high cholesterol.
  • are currently being treated for arthritis or an inflammatory condition, such as arthritis, gout, lupus or Sjogren's syndrome.
  • are currently being treated for cardiovascular disease, high blood pressure, fibromyalgia, or irritable bowel syndrome.
  • are pregnant.
  • regularly consume cherries or are allergic to cherries.
  • currently use anti-inflammatory medications.
  • have used corticosteroids in the last two months.
  • are not willing to follow a low polyphenol diet.

Outcomes

Primary Outcomes

Changes in glucose regulation assessed via glycated albumin (%).

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in glucose regulation assessed via insulin (mIU/L)

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in inflammation measured via erythrocyte sedimentation rate (mm/hour)

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in sleep quantity (hours and minutes) assessed via daily survey.

Time Frame: daily for 30 days

Changes in sleep quality measured via 100mm visual analogue scale.

Time Frame: daily for 30 days

Changes in gut microbiome bacterial counts

Time Frame: baseline, 14 days, and 30 days post supplementation.

Changes in inflammation measured via tumor necrosis factor alpha (pg/mL)

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in inflammation measured via c-reactive protein (mg/L) and uric acid (mg/dL).

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in glucose regulation assessed via plasma glucose (mg/dL)

Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.

Study Sites (1)

Loading locations...

Similar Trials